Specifically, we demonstrated that microRNA-29a (miR-29a) functions as a tumor suppressor in NSCLC by regulating CEACAM6, suggesting that the miR-29a–CEACAM6 axis is a potential therapeutic target [20]. The gene discussed is CEACAM6; the disease is neoplasm.